Grieco A J
Am J Med Sci. 1977 Mar-Apr;273(2):120-32.
Homocystinuria with elevated plasma homocysteine and methionine levels is the result of deficient activity of cystathionine synthetase, the enzyme catalyzing conversion of homocysteine to cystathionine. It is inherited as an autosomal recessive trait with a worldwide distribution. The major clinical manifestations result from the elevated plasma homocysteine level. The excitotoxic effect of homocysteic acid accounts for mental retardation and seizures. Interference with collagen cross-linking by sulfhydryl groups of homocysteine causes ectopia lentis and skeletal deformities. Sulfation factor-like effects contribute to disruption of vascular endothelium, which is followed by platelet thrombosis and widespread arterial and venous occlusions. Low methionine homocystinuria, with deficient remethylation of homocysteine, results from deranged vitamin B(12) metabolism and from deficient 5,10-methylene-tetrahydrofolate reductase. Administration of azaribine produces homocystinuria by mechanism not yet elucidated.
血浆同型半胱氨酸和蛋氨酸水平升高的同型胱氨酸尿症是胱硫醚合成酶活性不足的结果,该酶催化同型半胱氨酸转化为胱硫醚。它作为常染色体隐性性状遗传,在全球范围内均有分布。主要临床表现源于血浆同型半胱氨酸水平升高。同型半胱氨酸的兴奋毒性作用导致智力发育迟缓及癫痫发作。同型半胱氨酸的巯基对胶原交联的干扰会引起晶状体异位和骨骼畸形。类硫酸化因子效应导致血管内皮破坏,随后引发血小板血栓形成及广泛的动静脉闭塞。低蛋氨酸同型胱氨酸尿症,伴有同型半胱氨酸再甲基化不足,是由维生素B12代谢紊乱及5,10 - 亚甲基四氢叶酸还原酶缺乏所致。阿扎立宾通过尚未阐明的机制导致同型胱氨酸尿症。